The World Journal of Nuclear Medicine is sponsored by the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), WARMTH is an incorporated charity, registered in the United States of America. WARMTH encourages the use of radionuclide therapy to reduce human disease with a particular emphasis in delivery of that care in the developing world. There is a common desire to educate and share knowledge across both developed and developing nations. WARMTH has no editorial control over the WJNM but it's governing board appoints the editor in chief and provides financial support.
The World Journal of Nuclear Medicine is sponsored by the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), WARMTH is an incorporated charity, registered in the United States of America. WARMTH encourages the use of radionuclide therapy to reduce human disease with a particula...
Diagnostic accuracy of technetium‑99m‑octreotide in imaging neuroendocrine tumors, Oman hospital ...
Diagnostic accuracy of technetium‑99m‑octreotide in imaging neuroendocrine tumors, Oman hospital ...
Radioactive iodine (I‑131) therapy isolation rooms: Introduction of lead glass ...